Travel Vaccines Market to 2017 - Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market - GBI Research Reports

Travel Vaccines Market to 2017 - Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market

Travel Vaccines Market to 2017 - Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market - GBI Research Reports
Travel Vaccines Market to 2017 - Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market
Published Apr 11, 2011
105 pages — Published Apr 11, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research, the leading business intelligence provider, has released its latest research, Travel Vaccines Market to 2017 Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market, which provides insights into the global travel vaccines market and market forecasts until 2017. The report provides an in-depth analysis of the top seven therapeutic indications for which travel vaccines are often prescribed, which includes hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis and meningococcal meningitis. In addition, the report also includes insights into the travel vaccines R&D pipeline.

Scope

The scope of this report includes -
- Data and analysis on the global travel vaccines market.
- Annualized market data for the travel vaccines market from 2002 to 2010, with forecasts to 2017 for top seven geographies which includes the US, the UK, France, Germany, Italy, Spain and Japan.
- Market data on the therapeutic landscape which covers hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis and meningococcal meningitis, including market size, market share and cost of vaccination.
- Key drivers and restraints that have had a significant impact on the market and on each indication.
- The competitive landscape of the global travel vaccine market, which includes companies such as Sanofi-Pasteur, GlaxoSmithKline, Merck, Novartis and Intercell.
- Key M&A activities and Licensing Agreements that took place from 2005 to 2011 in the global travel vaccines market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth.
- Devise a more tailored country strategy through the understanding of key drivers and barriers of the regions antibacterial market.
- Develop key strategic initiatives by understanding the key focus areas and top selling antibacterial molecules of leading companies.
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

  
Source:
Document ID
GBIHC093MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents37
  List of Tables53
  List of Figures82
Global Travel Vaccines Market to 2017 Introduction102
  GBI Research Report Guidance111
Global Travel Vaccines Market to 2017 Market Overview123
  Introduction121
  Revenue Forecasts for the Travel Vaccines Market121
  Drivers and Barriers for the Travel Vaccines Market131
    Drivers for the Travel Vaccines Market131
      Increase in Outbound travel to Asia and South America131
      Increasing Antimicrobial Resistance131
      Emergence of New Vaccines131
      Higher Incidence of Travel-Related Diseases in Emerging Economies141
    Barriers for the Travel Vaccines Market141
      Low Vaccination Coverage141
Global Travel Vaccines Market to 2017 Geographical Landscape1514
  Revenue Analysis by Geography152
    The US171
      Revenue171
      Cost of Vaccination181
      Vaccination Coverage191
    Top Five Countries of Europe201
      Revenue201
      Cost of Vaccination211
      Vaccination Coverage221
    Japan231
      Revenue231
      Cost of Vaccination241
      Vaccination Coverage251
    Rest of the World261
      Revenue261
      Cost of Vaccination271
      Vaccination Coverage281
Global Travel Vaccines Market to 2017 Therapeutic Landscape2937
  Hepatitis A291
    Introduction291
      Geographical Distribution of Hepatitis A291
    Revenue301
    Cost of Vaccination311
    Vaccination Coverage321
    Drivers and Barriers for the Hepatitis A Market331
      Drivers for the Hepatitis A Market331
      Barriers for the Hepatitis A Market331
  Hepatitis B341
    Introduction341
      Geographical Distribution of Hepatitis B341
    Revenue351
    Cost of Vaccination361
    Vaccination Coverage371
    Drivers and Barriers for the Hepatitis B Market381
      Drivers for the Hepatitis B Market381
      Barriers for the Hepatitis B Market381
  Rabies391
    Introduction391
      Geographical Distribution of Rabies391
    Revenue401
    Cost of Vaccination411
    Vaccination Coverage421
    Drivers and Barriers for the Rabies Market431
      Drivers for the Rabies Market431
      Barriers for the Rabies Market431
  Typhoid Fever441
    Introduction441
      Geographical Distribution of Rabies441
    Revenue451
    Cost of Vaccination461
    Vaccination Coverage471
    Drivers and Barriers for the Typhoid Fever Market481
      Drivers for Typhoid Fever481
      Barriers for Typhoid Fever481
  Yellow Fever491
    Introduction491
      Geographical Distribution of Yellow Fever491
    Revenue501
    Cost of Vaccination511
    Vaccination Coverage521
    Drivers and Barriers for the Yellow Fever Market531
      Drivers for the Yellow Fever Market531
      Barriers for the Yellow Fever Market531
  Japanese Encephalitis541
    Introduction541
      Geographical Distribution of Japanese Encephalitis541
    Revenue551
    Cost of Vaccination561
    Vaccination Coverage571
    Drivers and Barriers for the Japanese Encephalitis Market581
      Drivers for Japanese Encephalitis581
      Barriers for Japanese Encephalitis581
  Meningococcal Meningitis591
    Introduction591
      Geographical Distribution of Meningococcal Meningitis591
    Revenue601
    Cost of Vaccination611
    Vaccination Coverage621
    Drivers and Barriers for the Meningococcal Meningitis Market631
      Drivers for the Meningococcal Meningitis Market631
      Barriers for the Meningococcal Meningitis Market631
  Enterotoxigenic Escherichia Coli (Traveler s Diarrhea)641
    Introduction641
      Geographical Distribution of Enterotoxigenic Escherischia Coli641
    Drivers and Barriers for the Enterotoxigenic Escherichia Coli Market651
      Drivers for Enterotoxigenic Escherischia Coli651
      Barriers for Enterotoxigenic Escherischia Coli651
Travel Vaccines Market Product Pipeline Analysis6618
  Introduction662
    Research and Development Pipeline Hepatitis A Vaccines681
      Overview681
      Drugs under Clinical Development681
    Research and Development Pipeline Hepatitis B Vaccines691
      Overview691
      Drugs under Clinical Development695
    Research and Development Pipeline Rabies Vaccines741
      Overview741
      Drugs under Clinical Development751
    Research and Development Pipeline Typhoid Fever Vaccines761
      Overview761
      Drugs under Clinical Development762
    Research and Development Pipeline Yellow Fever Vaccines781
      Overview781
      Drugs under Clinical Development781
    Research and Development Pipeline Japanese Encephalitis Vaccines791
      Overview791
      Drugs in Clinical Development791
    Research and Development Pipeline Enterotoxigenic Escherichia Coli Vaccines801
      Overview801
      Drugs under Clinical Development801
    Research and Development Pipeline Meningococcal Meningitis Vaccines811
      Overview811
      Drugs under Clinical Development813
Travel Vaccines Market Competitive Landscape848
  Market Share Analysis: Travel Vaccines Market841
  Competitive Profiling851
    Sanofi Pasteur851
      Overview851
      Travel Vaccines851
      SWOT Analysis861
    GlaxoSmithKline plc871
      Overview871
      Travel Vaccines871
      SWOT Analysis881
    Merck &Co., Inc881
      Overview891
      Travel Vaccines891
      SWOT Analysis891
    Novartis AG901
      Overview901
      Travel Vaccines901
      SWOT Analysis901
    Intercell AG911
      Overview911
      Travel Vaccines911
      SWOT Analysis911
Travel Vaccines Market M&A Landscape9211
  M&A Landscape921
    M&A Deals by Year921
    M&A Deals by Geography931
    M&A Deals by Value941
    Major M&A Deals by Value951
    M&A Deals by Deal Type961
    M&A Deals by Deal Sub-Type971
  R&D Licensing Agreements981
    Deals by Year981
    Deals by Geography991
    Deals by Value ($)1001
  Co-Developments1011
    Co-Developments by Year1011
    Co-developments by Geography1021
Travel Vaccines Market Appendix1033
  Market Definitions1031
  Abbreviations1031
  Research Methodology1032
    Coverage1031
    Secondary Research1041
    Primary Research1041
    Expert Panel Validation1041
  Contact Us1051
  Disclaimer1051
  Sources1051

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Travel Vaccines Market to 2017 - Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market" Apr 11, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Travel-Vaccines-Market-to-2017-Growth-in-International-Travel-and-Higher-Incidences-of-Infectious-Diseases-in-Emerging-Economies-to-Drive-the-Market-2115-201>
  
APA:
GBI Research Reports. (2011). Travel Vaccines Market to 2017 - Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market Apr 11, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Travel-Vaccines-Market-to-2017-Growth-in-International-Travel-and-Higher-Incidences-of-Infectious-Diseases-in-Emerging-Economies-to-Drive-the-Market-2115-201>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.